Home
Conditions
Lymphatic Diseases

Clinical trial condition

Lymphatic Diseases

Explore clinical trials studying Lymphatic Diseases. Study availability and eligibility vary by location and protocol.

8,964 public trials 1,826 recruiting studies

Refine in advanced search Browse all conditions

Lymphatic Diseases trial results

Active, Not Recruiting

Cardiac Screening in Survivors of Hodgkin's Disease Treated With Mediastinal Irradiation

NCT00165425

Conditions: Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin's Disease, +7 more
Locations: Brigham and Women's Hospital Boston, Massachusetts, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Active, Not Recruiting

Obinutuzumab, Venetoclax, and Lenalidomide in Treating Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma

NCT02992522

Conditions: B-Cell, B-Cell Lymphoma, Unspecified, Burkitt Lymphoma, +30 more
Locations: Emory University Atlanta, Georgia, United States

Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States

View Trial Details

Active, Not Recruiting

Study of BGB-11417 Monotherapy in Participants With Relapsed or Refractory Mantle Cell Lymphoma

NCT05471843

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
Locations: University of Alabama At Birmingham Hospital Birmingham, Alabama, United States

Medstar Georgetown University Hospital Washington D.C., District of Columbia, United States

Fort Wayne Medical Oncology and Hematology Fort Wayne, Indiana, United States

Des Moines Oncology Research Association Des Moines, Iowa, United States

View all 104 locations

View Trial Details

Active, Not Recruiting

Modified Immune Cells (CD19/CD20 CAR-T Cells) in Treating Patients With Recurrent or Refractory B-Cell Lymphoma or Chronic Lymphocytic Leukemia

NCT04007029

Conditions: CD19 Positive, CD20 Positive, Chronic Disease, +33 more
Locations: UCLA / Jonsson Comprehensive Cancer Center Los Angeles, California, United States

View Trial Details

Active, Not Recruiting

A Post-treatment Program to Identify and Manage Complications Related to Oncology or Hematology Treatments in Cancer Survivors.

NCT04671693

Conditions: Acute Myeloid Leukemia, Ewing's Sarcoma, Hematologic Diseases, +24 more
Locations: Centre Leon Berard Lyon, France

View Trial Details

Active, Not Recruiting

Development and Usability Evaluation of an Arm Circumference Measurement Tool For Patients Undergoing Breast Surgery

NCT07154771

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +8 more
Locations: Gülhane Training and Research Hospital, University of Health Sciences Ankara, Turkey (Türkiye)

View Trial Details

Active, Not Recruiting

Pembrolizumab and Vorinostat in Patients With Relapsed or Refractory DLBCL, FCL or HL.

NCT03150329

Conditions: Grade 3b Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +25 more
Locations: City of Hope Medical Center Duarte, California, United States

View Trial Details

Active, Not Recruiting

Polatuzumab Vedotin, Rituximab, Ifosfamide, Carboplatin, and Etoposide (PolaR-ICE) as Initial Salvage Therapy for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma

NCT04665765

Conditions: Diffuse Large B-Cell Lymphoma Unclassifiable, Hemic and Lymphatic Diseases, Immune System Diseases, +15 more
Locations: City of Hope Medical Center Duarte, California, United States

Emory University Atlanta, Georgia, United States

View Trial Details

Active, Not Recruiting

Cirmtuzumab Consolidation for Treatment of Patients With Detectable CLL on Venetoclax

NCT04501939

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations: UCSD Koman Family Outpatient Pavilion San Diego, California, United States

View Trial Details

Active, Not Recruiting

Targeting the IPA and Matching for the Non-Inherited Maternal Antigen for Haplo-Cord Transplantation

NCT01810588

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hematologic Malignancies, +12 more
Locations: University of Chicago Medical Center Chicago, Illinois, United States

Weill Cornell Medical College New York, United States

View Trial Details

Lymphatic Diseases

Lymphatic Diseases trial results

Related conditions